임상 한눈에 보기

• 1건의 ClinicalTrials.gov 임상 기록
• 임상시험 탭에서 enrollment 상위 목록을 불러올 수 있습니다
• Phase: Phase 2
• Status: Completed
• 주요 endpoint: Change from baseline in best corrected visual acuity in the treated eye · Change from baseline in the central visual field in the treated eye as determined by microperimetry · Change from baseline in the area of surviving retinal pigment epithelium in the treated eye as measured by fundus autofluorescence · compared to the untreated fellow eye (control eye) after randomisation of treatment to one eye or the other
• 등록 대상자(표본 합산): 약 30명

수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다. 효능 수치는 선택한 등록 결과이며 전적응증 값이 아닙니다.